People and Business News — 2/23
People News
Velocity Clinical Research has expanded its European senior executive team. Évelyne Newton joins as Vice President of Business Development, Sandra Stark as Vice President of European Operations and Maria Lehretz is the new Medical Director.
MMS Holdings announced the appointment of Chris Schoonmaker as Chief Operating Officer and Ashu Tandon as Chief Commercial Officer.
Sunitha Mathew, MS, has joined Westat's leadership team as its new Clinical Research Practice Director.
Clinical ink announced that healthcare industry veteran Jonathan Goldman MD has joined the company as Chief Executive Officer.
Business News
Vakzine Projekt Management GmbH announced the successful completion of a clinical client project with AntiBKV, an antibody targeting BK polyomavirus infection in renal transplant patients, for Memo Therapeutics AG, Switzerland.
Spaulding Clinical announced early results for a clinical trial as a part of the FDA’s proactive effort to address the opioid crisis and reduce opioid overdoses and deaths.
Verisense Health, Inc. announced the four founding members of its Board of Advisors – Dr. William Crown, Paul Hartung, Dr. Ronald C. Kessler, and Josh Tolkoff.
Medidata announced it was positioned as a Leader in the IDC MarketScape “Worldwide Life Science R&D Risk-Based Monitoring Solutions 2022 Vendor Assessment (doc #US48061722).”
OCT Clinical announced they have successfully completed the enrollment of 3,000 patients in a COVID-19 vaccine study.
Recognition
Almac Group has won six CDMO Leadership Awards for 2023: Excellence in Capabilities (Small Pharma), Compatibility (Overall and Small Pharma), Expertise (Overall and Small Pharma), Quality (Overall and Small Pharma), Reliability (Overall and Small Pharma), and Service (Small Pharma).
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Managing Side Effects and Dosing in Off-Label GLP-1 Use with Help from Real-World Evidence
July 18th 2025Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how real-world data is helping researchers navigate gastrointestinal side effects, dose flexibility, and long-term tolerability in off-label GLP-1 use.
Anselamimab Misses Primary Endpoint in Phase III CARES Trials for AL Amyloidosis
July 17th 2025In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a prespecified subgroup analysis revealed meaningful improvements in survival and cardiovascular outcomes.
